The partner company, which was not named due to commercial interests and to protect launch plans, had “an established track record” of taking new products to pharmacies and wholesalers via its distribution network in the Balkan country.
The agreement would grant the firm exclusive distribution rights in Bulgaria in return for meeting annual sales targets, OptiBiotix said.
Fred Narbel, managing director of OPTI’s prebiotics division, added that the partner company expected to place an early order for a consumer launch of the product “in the near future”.
“We are delighted at the high level of interest we have received in SlimBiome from an industry which recognises the value of protective patents and trademarks, two industry awards, clinical studies demonstrating safety and efficacy, and now a medical device registration and CE mark. These all provide a clear differentiation from other weight loss products. increasing the likelihood of commercial success.”
The Bulgarian deal is the second partnership agreed for SlimBiome in the last three weeks, with OPTI having signed a distribution agreement for the product in Italy and Spain back on 20 March.
In early trading on Tuesday, OptiBiotix shares were down 1.2% at 82p.
--Adds share price--